Hibi T, Shitara N, Genka S, Fuchinoue T, Hayakawa I, Tsuchida T, Nomura K, Kondo T, Takakura K
Department of Neurosurgery, Tokyo Metropolitan Toshima Hospital, Japan.
Neurosurgery. 1992 Oct;31(4):643-50; discussion 650-1. doi: 10.1227/00006123-199210000-00005.
An analysis of 39 patients under 20 years of age with brain stem glioma treated with radiotherapy between 1977 and 1991 was undertaken. Twenty-eight (71.2%) of the patients responded well to initial radiotherapy, and 11 (28.8%) responded poorly. Median survival for the total patient population was 10 months. Response rates and median survivals were influenced by radiation dose: 45.5% and 9 months at doses less than 4499 cGy (n = 11), 83.3% and 13 months at doses between 4500 and 5499 cGy (n = 12), 66.7% and 11.5 months at doses between 5500 and 6499 cGy (n = 9), and 100% and 10 months at doses more than 6500 cGy (n = 7). Multivariate analysis revealed the response to initial radiotherapy was the only predictor of survival with radiation doses up to 6499 cGy. Four of the patients who responded well demonstrated radiological and/or histological calcification within or around the tumor at the time of clinical deterioration. Radiation injury was confirmed in two autopsy cases. The possibility that intratumoral radiation injury causes clinical deterioration is suggested.
对1977年至1991年间接受放疗的39例20岁以下脑干胶质瘤患者进行了分析。28例(71.2%)患者对初始放疗反应良好,11例(28.8%)反应不佳。全部患者的中位生存期为10个月。缓解率和中位生存期受放射剂量影响:剂量小于4499 cGy时(n = 11),缓解率为45.5%,中位生存期为9个月;剂量在4500至5499 cGy之间时(n = 12),缓解率为83.3%,中位生存期为13个月;剂量在5500至6499 cGy之间时(n = 9),缓解率为66.7%,中位生存期为11.5个月;剂量大于6500 cGy时(n = 7),缓解率为100%,中位生存期为10个月。多因素分析显示,对于放射剂量高达6499 cGy的情况,对初始放疗的反应是生存的唯一预测因素。4例反应良好的患者在临床病情恶化时,肿瘤内部或周围出现了放射学和/或组织学钙化。2例尸检病例证实存在放射损伤。提示肿瘤内放射损伤可能导致临床病情恶化。